Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS – Get Free Report) saw a significant decrease in short interest in June. As of June 30th, there was short interest totaling 12,601 shares, a decrease of 73.5% from the June 15th total of 47,607 shares. Based on an average trading volume of 336,404 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.
Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund
Several institutional investors have recently bought and sold shares of the company. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Neuberger Berman High Yield Strategies Fund in the third quarter valued at about $80,000. Integrity Advisory Solutions LLC acquired a new position in shares of Neuberger Berman High Yield Strategies Fund during the 4th quarter worth approximately $81,000. XTX Topco Ltd acquired a new position in shares of Neuberger Berman High Yield Strategies Fund in the second quarter valued at $113,000. Kestra Advisory Services LLC raised its holdings in Neuberger Berman High Yield Strategies Fund by 18.0% in the 4th quarter. Kestra Advisory Services LLC now owns 18,728 shares of the investment management company’s stock valued at $139,000 after acquiring an additional 2,857 shares during the period. Finally, CoreCap Advisors LLC acquired a new stake in Neuberger Berman High Yield Strategies Fund during the 2nd quarter worth approximately $119,000.
Neuberger Berman High Yield Strategies Fund Price Performance
NYSEAMERICAN NHS traded up $0.01 on Tuesday, reaching $6.21. The company had a trading volume of 118,761 shares, compared to its average volume of 240,018. The company’s fifty day moving average is $6.28 and its 200-day moving average is $6.83. Neuberger Berman High Yield Strategies Fund has a 1-year low of $6.06 and a 1-year high of $7.75.
Neuberger Berman High Yield Strategies Fund Dividend Announcement
About Neuberger Berman High Yield Strategies Fund
The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.
See Also
- Five stocks we like better than Neuberger Berman High Yield Strategies Fund
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Neuberger Berman High Yield Strategies Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strategies Fund and related companies with MarketBeat.com's FREE daily email newsletter.
